Table 2.
Risk factor management at follow-up | SAP n = 32 |
UAP/n-STEMI n = 15 |
P value |
---|---|---|---|
Aspirin n (%) | 31 (97%) | 15 (100%) | 1 |
Clopidogrel n (%) | 19 (59%) | 14 (93%) | 0.02 |
Statins n (%) | 28 (88%) | 15 (100%) | 0.29 |
Beta-blockers n (%) | 19 (59%) | 9 (60%) | 0.97 |
ACE-inhibitors/AT2-antagonists n (%) | 15 (49%) | 8 (53%) | 0.68 |
Smoking | 0.60 | ||
No n (%) | 7 (22%) | 3 (20%) | |
Active n (%) | 6 (19%) | 1 (7%) | |
Former n (%) | 19 (59%) | 11 (73%) |